Digestive Diseases and Sciences

, Volume 57, Issue 4, pp 1072–1082

Transjugular Intrahepatic Portosystemic Shunt for Portal Cavernoma with Symptomatic Portal Hypertension in Non-cirrhotic Patients

  • Xingshun Qi
  • Guohong Han
  • Zhanxin Yin
  • Chuangye He
  • Jianhong Wang
  • Wengang Guo
  • Jing Niu
  • Wei Zhang
  • Ming Bai
  • Daiming Fan
Original Article

Abstract

Background

Portal cavernoma is regarded as a contraindication to transjugular intrahepatic portosystemic shunt (TIPS).

Aim

To evaluate the feasibility, safety, and efficacy of TIPS for symptomatic portal hypertension in non-cirrhotic patients with portal cavernoma.

Methods

Between July 2002 and December 2009, 46 consecutive non-cirrhotic patients with portal cavernoma were admitted to our center. Twenty patients presented with variceal rebleeding (n = 20) and refractory ascites (n = 1), and were treated with TIPS. They were followed until either death or July 2010. Data were compared using the Fisher’s exact test or t test.

Results

TIPS were successfully placed in 35% (7/20) of patients via a transjugular approach alone (n = 1), a combined transjugular/transhepatic approach (n = 4), and a combined transjugular/transsplenic approach (n = 2). TIPS were inserted in a large collateral vein in two patients in whom recanalization of the occluded main portal vein was impossible. Procedure-related complication was hepatic capsule perforation in one patient who was cured by medical therapy alone. Shunt dysfunction occurred in two patients, but TIPS revision was failed in one of them. Portosystemic pressure gradient was significantly reduced in TIPS success group (26.3 ± 1.1 vs. 12.4 ± 1.1 mmHg, p < 0.001). The incidence of variceal bleeding in TIPS success group is lower than that in TIPS failure group (14 vs. 69%, p = 0.057). In TIPS success group, two patients died of systemic infection and accident, respectively. In TIPS failure group, two patients died of liver failure.

Conclusions

TIPS procedures are feasible and safe in selected patients with portal cavernoma. Successful TIPS insertions may decrease the incidence of variceal rebleeding.

Keywords

Portal cavernoma Extrahepatic portal vein obstruction Portal hypertension Transjugular intrahepatic portosystemic shunt Variceal bleeding 

Abbreviations

CDUS

Color Doppler ultrasound

CT

Computed tomography

EHPVO

Extrahepatic portal vein obstruction

INR

Internationalized normalized ratio

MPV

Main portal vein

TIPS

Transjugular intrahepatic portosystemic shunt

References

  1. 1.
    Song B, Min P, Oudkerk M, et al. Cavernous transformation of the portal vein secondary to tumor thrombosis of hepatocellular carcinoma: spiral CT visualization of the collateral vessels. Abdom Imaging. 2000;25:385–393.PubMedCrossRefGoogle Scholar
  2. 2.
    Kauzlaric D, Petrovic M, Barmeir E. Sonography of cavernous transformation of the portal vein. AJR Am J Roentgenol. 1984;142:383–384.PubMedGoogle Scholar
  3. 3.
    Ide T, Ohno Y, Nakanuma Y, Kanematsu T. Early development of cavernomatous vasculatures in portal venous thrombosis: morphometric kinetics in rabbit model. Hepatol Res. 2003;27:136–142.PubMedCrossRefGoogle Scholar
  4. 4.
    Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol. 2000;32:865–871.PubMedCrossRefGoogle Scholar
  5. 5.
    DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology. 2009;49:1729–1764.PubMedCrossRefGoogle Scholar
  6. 6.
    de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53:762–768.PubMedCrossRefGoogle Scholar
  7. 7.
    Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology. 2005;41:386–400.PubMedCrossRefGoogle Scholar
  8. 8.
    Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology. 2010;51:306.PubMedCrossRefGoogle Scholar
  9. 9.
    Fanelli F, Angeloni S, Salvatori FM, et al. Transjugular intrahepatic portosystemic shunt with expanded-polytetrafluoroethylene-covered stents in non-cirrhotic patients with portal cavernoma. Dig Liver Dis. 2011;43:78–84.PubMedCrossRefGoogle Scholar
  10. 10.
    Wils A, van der Linden E, van Hoek B, Pattynama PM. Transjugular intrahepatic portosystemic shunt in patients with chronic portal vein occlusion and cavernous transformation. J Clin Gastroenterol. 2009;43:982–984.PubMedCrossRefGoogle Scholar
  11. 11.
    Tuite DJ, Rehman J, Davies MH, Patel JV, Nicholson AA, Kessel DO. Percutaneous transsplenic access in the management of bleeding varices from chronic portal vein thrombosis. J Vasc Interv Radiol. 2007;18:1571–1575.PubMedCrossRefGoogle Scholar
  12. 12.
    Senzolo M, Tibbals J, Cholongitas E, Triantos CK, Burroughs AK, Patch D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther. 2006;23:767–775.PubMedCrossRefGoogle Scholar
  13. 13.
    Walser EM, Soloway R, Raza SA, Gill A. Transjugular portosystemic shunt in chronic portal vein occlusion: importance of segmental portal hypertension in cavernous transformation of the portal vein. J Vasc Interv Radiol. 2006;17:373–378.PubMedCrossRefGoogle Scholar
  14. 14.
    Senzolo M, Cholongitas E, Tibballs J, et al. Relief of biliary obstruction due to portal vein cavernoma using a transjugular intrahepatic portosystemic shunt (TIPS) without the need for long-term stenting. Endoscopy. 2006;38:760.PubMedCrossRefGoogle Scholar
  15. 15.
    Bilbao JI, Elorz M, Vivas I, Martinez-Cuesta A, Bastarrika G, Benito A. Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients. Cardiovasc Interv Radiol. 2004;27:474–480.CrossRefGoogle Scholar
  16. 16.
    Qi X, Han G, Yin Z, et al. Cavernous vessels around a patent portal trunk in the liver hilum. Abdom Imaging. 2011. doi:10.1007/s00261-011-9779-9.
  17. 17.
    Qi X, Han G, Bai M, Fan D. Stage of portal vein thrombosis. J Hepatol. 2011;54:1080–1082.PubMedCrossRefGoogle Scholar
  18. 18.
    Qi X, Han G, Wang J, Wu K, Fan D. Degree of portal vein thrombosis. Hepatology. 2010;51:1089–1090.PubMedCrossRefGoogle Scholar
  19. 19.
    Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the international ascites club. Hepatology. 2003;38:258–266.PubMedCrossRefGoogle Scholar
  20. 20.
    Han G, Qi X, He C, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol. 2011;54:78–88.PubMedCrossRefGoogle Scholar
  21. 21.
    Qi X, Han G, Yin Z, et al. A large portal vein: a rare finding of recent portal vein thrombosis. Case Rep Gastroenterol. 2011;5:33–39.PubMedCrossRefGoogle Scholar
  22. 22.
    Bilbao JI, Arias M, Herrero JI, et al. Percutaneous transhepatic treatment of a posttransplant portal vein thrombosis and a preexisting spontaneous splenorenal shunt. Cardiovasc Interv Radiol. 1995;18:323–326.Google Scholar
  23. 23.
    Liang HL, Yang CF, Pan HB, Chen CK, Chang JM. Percutaneous transsplenic catheterization of the portal venous system. Acta Radiol. 1997;38:292–295.PubMedGoogle Scholar
  24. 24.
    Adani GL, Baccarani U, Risaliti A, et al. Percutaneous transhepatic portography for the treatment of early portal vein thrombosis after surgery. Cardiovasc Interv Radiol. 2007;30:1222–1226.CrossRefGoogle Scholar
  25. 25.
    Bertram H, Pfister ED, Becker T, Schoof S. Transsplenic endovascular therapy of portal vein stenosis and subsequent complete portal vein thrombosis in a 2-year-old child. J Vasc Interv Radiol. 2010;21:1760–1764.PubMedCrossRefGoogle Scholar
  26. 26.
    Radosevich PM, Ring EJ, LaBerge JM, et al. Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion. Radiology. 1993;186:523–527.PubMedGoogle Scholar
  27. 27.
    Stein M, Link DP. Symptomatic spleno-mesenteric-portal venous thrombosis: recanalization and reconstruction with endovascular stents. J Vasc Interv Radiol. 1999;10:363–371.PubMedCrossRefGoogle Scholar
  28. 28.
    Van Ha TG, Hodge J, Funaki B, et al. Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis. Cardiovasc Interv Radiol. 2006;29:785–790.CrossRefGoogle Scholar
  29. 29.
    Yamagami T, Takeuchi Y, Sonoyama T, et al. Non-cavernomatous superior mesenteric thrombosis successfully recanalized with interventional radiological procedures carried out with a combination transmesenteric and transjugular approaches. Australas Radiol. 2006;50:495–499.PubMedCrossRefGoogle Scholar
  30. 30.
    Matsui O, Yoshikawa J, Kadoya M, et al. Transjugular intrahepatic portosystemic shunt after previous recanalization of a chronically thrombosed portal vein via a transmesenteric approach. Cardiovasc Interv Radiol. 1996;19:352–355.CrossRefGoogle Scholar
  31. 31.
    Rozenblit G, DelGuercio LR, Savino JA, et al. Transmesenteric-transfemoral method of intrahepatic portosystemic shunt placement with minilaparotomy. J Vasc Interv Radiol. 1996;7:499–506.PubMedCrossRefGoogle Scholar
  32. 32.
    Perarnau JM, Baju A, D’Alteroche L, Viguier J, Ayoub J. Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis. Eur J Gastroenterol Hepatol. 2010;22:1093–1098.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Xingshun Qi
    • 1
  • Guohong Han
    • 1
  • Zhanxin Yin
    • 1
  • Chuangye He
    • 1
  • Jianhong Wang
    • 2
  • Wengang Guo
    • 1
  • Jing Niu
    • 1
  • Wei Zhang
    • 1
  • Ming Bai
    • 1
  • Daiming Fan
    • 3
  1. 1.Department of Liver Disease and Digestive Interventional RadiologyXijing Hospital of Digestive Diseases, Fourth Military Medical UniversityXi’anChina
  2. 2.Department of UltrasoundXijing Hospital of Digestive Diseases, Fourth Military Medical UniversityXi’anChina
  3. 3.State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive DiseasesFourth Military Medical UniversityXi’anChina

Personalised recommendations